AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 154 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $251,000 | +64.1% | 26,744 | +34.0% | 0.00% | +33.3% |
Q2 2020 | $153,000 | +104.0% | 19,960 | +65.3% | 0.00% | +50.0% |
Q1 2020 | $75,000 | -90.5% | 12,073 | -82.3% | 0.00% | -87.5% |
Q3 2019 | $789,000 | -24.7% | 68,278 | -34.9% | 0.02% | -15.8% |
Q2 2019 | $1,048,000 | +95.2% | 104,890 | +196.8% | 0.02% | -24.0% |
Q4 2018 | $537,000 | +270.3% | 35,338 | +385.8% | 0.02% | +212.5% |
Q3 2018 | $145,000 | -26.4% | 7,274 | -31.7% | 0.01% | -27.3% |
Q3 2017 | $197,000 | -18.3% | 10,653 | +53.8% | 0.01% | -42.1% |
Q4 2016 | $241,000 | +677.4% | 6,928 | +430.9% | 0.02% | +850.0% |
Q2 2016 | $31,000 | -90.1% | 1,305 | -83.5% | 0.00% | -87.5% |
Q3 2015 | $314,000 | -88.5% | 7,900 | -80.0% | 0.02% | -88.0% |
Q2 2015 | $2,726,000 | +887.7% | 39,472 | +681.6% | 0.13% | +850.0% |
Q1 2015 | $276,000 | +331.2% | 5,050 | +236.7% | 0.01% | +366.7% |
Q4 2014 | $64,000 | – | 1,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 740,585 | $17,330,000 | 8.11% |
Palo Alto Investors LP | 2,906,194 | $68,005,000 | 5.28% |
Opaleye Management Inc. | 220,000 | $5,148,000 | 3.21% |
Endurant Capital Management LP | 265,180 | $6,205,000 | 2.01% |
FALCON POINT CAPITAL, LLC | 381,081 | $8,917,000 | 1.54% |
STELLIAM INVESTMENT MANAGEMENT, LP | 1,470,000 | $34,398,000 | 1.06% |
AlphaOne Investment Services, LLC | 91,824 | $2,149,000 | 0.88% |
ASHFORD CAPITAL MANAGEMENT INC | 153,325 | $3,588,000 | 0.85% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 55,097 | $1,289,000 | 0.84% |
Camber Capital Management LP | 600,000 | $14,040,000 | 0.82% |